The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands

Urman S, Gaus K, Yang Y, Strijowski U, Sewald N, De Pol S, Reiser O (2007)
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 46(21): 3976-3978.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ;
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Urman S, Gaus K, Yang Y, et al. The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2007;46(21):3976-3978.
Urman, S., Gaus, K., Yang, Y., Strijowski, U., Sewald, N., De Pol, S., & Reiser, O. (2007). The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 46(21), 3976-3978.
Urman, S., Gaus, K., Yang, Y., Strijowski, U., Sewald, N., De Pol, S., and Reiser, O. (2007). The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 46, 3976-3978.
Urman, S., et al., 2007. The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 46(21), p 3976-3978.
S. Urman, et al., “The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands”, ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, vol. 46, 2007, pp. 3976-3978.
Urman, S., Gaus, K., Yang, Y., Strijowski, U., Sewald, N., De Pol, S., Reiser, O.: The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 46, 3976-3978 (2007).
Urman, Sylwia, Gaus, Katharina, Yang, Yi, Strijowski, Ulf, Sewald, Norbert, De Pol, Silvia, and Reiser, Oliver. “The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands”. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION 46.21 (2007): 3976-3978.
This data publication is cited in the following publications:
This publication cites the following data publications:

7 Citations in Europe PMC

Data provided by Europe PubMed Central.

The integrin ligand c(RGDf(NMe)Nal) reduces neointimal hyperplasia in a polymer-free drug-eluting stent system.
Rechenmacher F, Steigerwald K, Laufer B, Neubauer S, Kapp TG, Li L, Mas-Moruno C, Joner M, Kessler H., ChemMedChem 9(7), 2014
PMID: 24706601
Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
Conradi J, Huber S, Gaus K, Mertink F, Royo Gracia S, Strijowski U, Backert S, Sewald N., Amino Acids 43(1), 2012
PMID: 21915696
α/β-Peptide foldamers: state of the art.
Pilsl LK, Reiser O., Amino Acids 41(3), 2011
PMID: 21462000
Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of alphaVbeta3 integrin.
Aufort M, Gonera M, Chaignon N, Le Clainche L, Dugave C., Eur J Med Chem 44(9), 2009
PMID: 19303174
Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides.
Urbahns K, Harter M, Albers M, Schmidt D, Stelte-Ludwig B, Bruggemeier U, Vaupel A, Keldenich J, Lustig K, Tsujishita H, Gerdes C., Bioorg. Med. Chem. Lett. 17(22), 2007
PMID: 17910915

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 17394270
PubMed | Europe PMC

Search this title in

Google Scholar